-
J&J COVID-19 vaccine trial paused due to unexplained illness in participant
expresspharma
October 15, 2020
The participant's illness is being reviewed and evaluated by an independent data and safety monitoring board, as well as the company's clinical and safety physicians, informed J&J.
-
Potential COVID-19 vaccines not affected by dominant "G-Strain"
worldpharmanews
October 14, 2020
Vaccines currently being developed for COVID-19 should not be affected by recent mutations in the virus, according to a new study involving a University of York virologist.
-
Pfizer and BioNTech enter Covid-19 vaccine deal with New Zealand
pharmaceutical-technology
October 14, 2020
Pfizer and BioNTech have entered an agreement with the New Zealand Government to supply 1.5 million doses of their potential Covid-19 vaccine.
-
Blue Dart strengthens its temperature controlled logistics solution for supply of COVID-19 vaccine
expresspharma
October 12, 2020
Blue Dart provides reefer vehicles (cold chain) services to the vaccine sector to ensure seamless transport of shipment.
-
Bharat Biotech told to provide phase II data of Covaxin before phase III trial
expresspharma
October 12, 2020
The SEC also observed that the vaccine was well-tolerated in all dose groups and no serious adverse events have been reported so far.
-
Mexico pays nearly $160 mn for COVAX vaccine plan
expresspharma
October 12, 2020
The latest payment will allow Mexico to acquire enough doses of a vaccine to immunise up to a fifth of the country’s population of around 125 million people.
-
Occupational hazard, exposure risk are key factors for prioritising COVID-19 vaccine: Dr Vardhan
expresspharma
October 12, 2020
Adequate safety and efficacy data is required for emergency use authorization vaccine approval for ensuring patient safety, he said.
-
European Commission scores 200 million doses of J&J’s potential COVID-19 vaccine
pharmatimes
October 10, 2020
The European Commission, acting on behalf of the European Union member states, has approved an advanced purchase agreement for 200 million doses of J&J’s COVID-19 vaccine.
-
China joins COVAX initiative
expresspharma
October 10, 2020
China has joined a global COVID-19 vaccine initiative co-led by the World Health Organization (WHO).
-
INOVIO COVID-19 vaccine trials on partial hold after additional queries from US FDA
expresspharma
October 10, 2020
Working to address the FDA's questions and plans to respond in October, informed the company.